本页面由Tiger Trade Technology Pte. Ltd.提供服务

Precision Biosciences Inc

4.77
+0.42009.66%
成交量:19.13万
成交额:89.09万
市值:1.15亿
市盈率:-0.57
高:4.80
开:4.37
低:4.27
收:4.35
52周最高:8.82
52周最低:3.53
股本:2,407.18万
流通股本:2,282.25万
量比:1.01
换手率:0.84%
股息:- -
股息率:- -
每股收益(TTM):-8.3225
每股收益(LYR):1.04
净资产收益率:-205.16%
总资产收益率:-45.34%
市净率:6.90
市盈率(LYR):4.59

数据加载中...

2026/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/11

重要事件披露

Form 8-K - Current report
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

重要事件披露

Form 8-K - Current report
2025/12/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/12

重要事件披露

Form 8-K - Current report
2025/11/10

重要事件披露

Form 8-K - Current report
2025/11/10

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

重要事件披露

Form 8-K - Current report
2025/09/02

重要事件披露

Form 8-K - Current report